TickerFacts.

Bausch & Lomb Corp (BLCO): Revenue

Annual figures by period end, from SEC filings.

$5.10B
Year ended 2025-12-31
$5.32B
Trailing 12 months to 2026-06-30
+10.6%
3-year compound annual growth
+8.4%
5-year compound annual growth
2020-12-31: $3.41B2021-12-31: $3.77B2022-12-31: $3.77B2023-12-31: $4.15B2024-12-31: $4.79B2025-12-31: $5.10B$5.10B
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$5.10B+6.5%2026-02-18, From 2025-01-01
2024-12-31$4.79B+15.6%2026-02-18, From 2024-01-01
2023-12-31$4.15B+10.0%2026-02-18, From 2023-01-01
2022-12-31$3.77B+0.1%2025-02-19, From 2022-01-01
2021-12-31$3.77B+10.3%2024-02-21, From 2021-01-01
2020-12-31$3.41Bn/a2023-02-22, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Bausch & Lomb Corp (BLCO)2025-12-31$5.10B+6.5%
Cooper Companies, Inc. (COO)2025-10-31$4.09B+5.1%
National Vision Holdings, Inc. (EYE)2026-01-03$1.99B+9.0%
Warby Parker Inc. (WRBY)2025-12-31$871.90M+13.0%
Staar Surgical Co (STAA)2026-01-02$239.44M-23.7%
RxSight, Inc. (RXST)2025-12-31$134.48M-3.9%
Innovative Eyewear Inc (LUCYW)2025-12-31$2.66M+62.6%

Compare BLCO, COO, EYE, WRBY side by side · Screen every company in Ophthalmic Goods ↗